Literature DB >> 26786696

Synthesis of new diarylamides with pyrimidinyl pyridine scaffold and evaluation of their anti-proliferative effect on cancer cell lines.

Ahmed Z Abdelazem1, Mohammad M Al-Sanea2, Hyun-Mee Park3, So Ha Lee4.   

Abstract

A new series of diarylamides, having a pyrimidinyl pyridine scaffold, was designed and synthesized. The target compounds were synthesized in three steps. A selected group from the target compounds was tested over a panel of 60 cancer cell lines at a single dose concentration of 10 μM, and the most active compound, 5j, was further tested in a five-dose testing mode to determine its IC50 value over the 60 cell lines. In single-dose testing mode, compound 5j showed the highest growth inhibition against the NCI-60 cancer cell lines, while other tested compounds showed a weak to moderate inhibitory activity against a range of different cancer cell lines. In five-dose testing mode, compound 5j showed strong inhibitory activity in micro molar range against many cancer cell lines. Its major activity was against melanoma cancer cell lines. Therefore, compound 5j is a promising hit compound targeting this severe form of cancer.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-proliferative effect; Diarylamide; Melanoma; Pyrimidinyl pyridine; Synthesis

Mesh:

Substances:

Year:  2016        PMID: 26786696     DOI: 10.1016/j.bmcl.2016.01.014

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

Review 1.  Pyridine: the scaffolds with significant clinical diversity.

Authors:  Sourav De; Ashok Kumar S K; Suraj Kumar Shah; Sabnaz Kazi; Nandan Sarkar; Subhasis Banerjee; Sanjay Dey
Journal:  RSC Adv       Date:  2022-05-20       Impact factor: 4.036

2.  Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety.

Authors:  Mohammad M Al-Sanea; Lizaveta Gotina; Mamdouh Fa Mohamed; Della Grace Thomas Parambi; Hesham A M Gomaa; Bijo Mathew; Bahaa G M Youssif; Khalid Saad Alharbi; Zainab M Elsayed; Mohamed A Abdelgawad; Wagdy M Eldehna
Journal:  Drug Des Devel Ther       Date:  2020-02-04       Impact factor: 4.162

3.  A New CDK2 Inhibitor with 3-Hydrazonoindolin-2-One Scaffold Endowed with Anti-Breast Cancer Activity: Design, Synthesis, Biological Evaluation, and In Silico Insights.

Authors:  Mohammad M Al-Sanea; Ahmad J Obaidullah; Mohamed E Shaker; Garri Chilingaryan; Mohammed M Alanazi; Nawaf A Alsaif; Hamad M Alkahtani; Sultan A Alsubaie; Mohamed A Abdelgawad
Journal:  Molecules       Date:  2021-01-14       Impact factor: 4.411

Review 4.  The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design.

Authors:  Yong Ling; Zhi-You Hao; Dong Liang; Chun-Lei Zhang; Yan-Fei Liu; Yan Wang
Journal:  Drug Des Devel Ther       Date:  2021-10-13       Impact factor: 4.162

5.  Synthesis and biological evaluation of small molecule modulators of CDK8/Cyclin C complex with phenylaminoquinoline scaffold.

Authors:  Mohammad M Al-Sanea
Journal:  PeerJ       Date:  2020-03-13       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.